<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="125948">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01760174</url>
  </required_header>
  <id_info>
    <org_study_id>N-20120041</org_study_id>
    <nct_id>NCT01760174</nct_id>
  </id_info>
  <brief_title>Comparing the Effect of TAP-catheter and Epidural Catheter on Postoperative Pain After Open Gynecologic Surgery</brief_title>
  <official_title>A Randomized Double Blind Trial Comparing the Effect of Transversus Abdominal Plane-catheter and Epidural Catheter on Postoperative Pain After Open Gynecologic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg Universityhospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aalborg Universityhospital</source>
  <oversight_info>
    <authority>Denmark: The Regional Committee on Biomedical Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the effect on postoperative pain of bolus administration of ropivacaine
      in Transversus abdominis plane catheter and continuous bupivacain-infusion in epidural
      catheters following open gynecologic surgery.The study is double blind. The hypothesis is
      that the effect of the two modes of pain treatment are equal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients for open gynecologic surgery will all receive both an epidural catheter and
      bilateral transversus abdominis plane (:TAP) catheters. After randomization in to two groups
      the patients receive either 1) intermittent boluses of ropivacaine in the TAP-catheters and
      isotonic potassium chloride-infusion i the epidural catheters or 2) intermittent isotonic
      potassium chloride-boluses i the TAP-catheters and bupivacain-infusion in the epidural
      catheters.

      The investigators record pain-score and consumption of opioids in the first 24 hours
      postoperatively as well as thermoanalgesia at dermatome-levels th10-th12.

      The investigators assume that the effect on postoperative pain after open gynecologic
      surgery is equal in the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain-score on numerical rating scale</measure>
    <time_frame>4 hours after first bolus in tranversus abdominis catheters</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Administration of opioids</measure>
    <time_frame>The first 24 hours after surgery.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain-score on numerical rating scale</measure>
    <time_frame>8 hours after first bolus in tranversus abdominis catheters</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain-score on numerical rating scale</measure>
    <time_frame>24 hours after first bolus in tranversus abdominis catheters</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Thermoanalgesia at dermatome-level th10-th12</measure>
    <time_frame>4 hours after first bolus in TAP-catherter</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Bupivacain-infusion in epidural catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacain-infusion in epidural catheter and intermittent isotonic potassium chloride bolus in transversus abdominis plane catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine bolus in transversus abdominis plane catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intermittent ropivacaine bolus in bilateral transversus abdominis plane catheter and isotonic potassium chloride infusion in epidural catheter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine bolus in transversus abdominis plane catheter</intervention_name>
    <description>Ropivacaine 7,5 mg/ml, 10-25 ml in each catheter, depending on patient weight, the total dose of ropivacaine is kept less than 3 mg/kg for every bolus. Bolus is given every 6 hours, the first bolus is given just after induction of general anesthesia and the last bolus after 24 hours.
In the epidural catheter a bolus of 8 ml isotonic potassium chloride is given and an infusion of isotonic potassium chloride, 4-7 ml/t depending on patient height is started and runs for the first 24 hours.</description>
    <arm_group_label>Ropivacaine bolus in transversus abdominis plane catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacain-infusion in epidural catheter</intervention_name>
    <description>Isotonic potassium chloride, 10-25 ml in each transversus abdominis catheter, depending on patient weight. Bolus is given every 6 hours, the first bolus is given just after induction of general anesthesia and the last bolus after 24 hours.
In the epidural catheter a bolus of 8 ml bupivacaine 2,5 mg/ml is given and an infusion of isotonic potassium chloride, 4-7 ml/t depending on patient height is started and runs for the first 24 hours</description>
    <arm_group_label>Bupivacain-infusion in epidural catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled for open gynecologic surgery

          -  acceptance to participate

        Exclusion Criteria:

          -  allergies to local analgetics

          -  daily use of strong opioids
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nils F Bjerregaard, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg Universityhospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bodil S Rasmussen, M.D. + PhD</last_name>
    <role>Study Director</role>
    <affiliation>Aalborg Sygehus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lone Nikolajsen, M.D, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas F Bendtsen, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nils F Bjerregaard, M.D.</last_name>
    <phone>0045 22 86 06 49</phone>
    <email>niheb@rn.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aalborg Hospital</name>
      <address>
        <city>Aalborg</city>
        <state>Region Nord</state>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nils F Bjerregaard, MD</last_name>
      <phone>0045 22 86 06 49</phone>
      <email>niheb@rn.dk</email>
    </contact>
    <investigator>
      <last_name>Nils F Bjerregaard, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 2, 2013</lastchanged_date>
  <firstreceived_date>July 26, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aalborg Hospital</investigator_affiliation>
    <investigator_full_name>Nils Bjerregaard</investigator_full_name>
    <investigator_title>Consultant Anesthetist</investigator_title>
  </responsible_party>
  <keyword>Transversus abdominis plane catheter</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
